In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow.
about
Recent Trends in Therapeutic Approaches for Diabetes Management: A Comprehensive UpdateTissue engineering approaches to cell-based type 1 diabetes therapyFrom Beta cell replacement to beta cell regeneration: implications for antidiabetic therapyMesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes MellitusTherapeutic potential of mesenchymal stem cells for oral and systemic diseasesStem cell treatment for Alzheimer's diseaseMultipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice.β-Cell regeneration mediated by human bone marrow mesenchymal stem cells.Cytokines inducing bone marrow SCA+ cells migration into pancreatic islet and conversion into insulin-positive cells in vivo.Adult stem cells as a renewable source of insulin-producing cellsLaminin 411 acts as a potent inducer of umbilical cord mesenchymal stem cell differentiation into insulin-producing cellsAutografting of bone marrow mesenchymal stem cells alleviates streptozotocin‑induced diabetes in miniature pigs: real-time tracing with MRI in vivo.Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia.The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells.Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1.Under a nonadherent state, bone marrow mesenchymal stem cells can be efficiently induced into functional islet-like cell clusters to normalize hyperglycemia in mice: a control studyDo we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.Stem cells as a therapeutic target for diabetes.Isolation, culture and evaluation of multilineage-differentiating stress-enduring (Muse) cells.Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERKPromoting long-term survival of insulin-producing cell grafts that differentiate from adipose tissue-derived stem cells to cure type 1 diabetesReversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cellsSecretion of immunoregulatory cytokines by mesenchymal stem cells.Generation of functional insulin-producing cells from neonatal porcine liver-derived cells by PDX1/VP16, BETA2/NeuroD and MafA.Cell-based regenerative strategies for treatment of diabetic skin wounds, a comparative study between human umbilical cord blood-mononuclear cells and calves' blood haemodialysateCombinatorial treatment of bone marrow stem cells and stromal cell-derived factor 1 improves glycemia and insulin production in diabetic mice.Adipose tissue-derived mesenchymal stem cells exert in vitro immunomodulatory and beta cell protective functions in streptozotocin-induced diabetic mice model.Pancreatic islet cell therapy for type I diabetes: understanding the effects of glucose stimulation on islets in order to produce better islets for transplantation.The application of umbilical cord blood cells in the treatment of diabetes mellitusDifferentiation of human labia minora dermis-derived fibroblasts into insulin-producing cellsLong-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation.Reprogramming liver-stem WB cells into functional insulin-producing cells by persistent expression of Pdx1- and Pdx1-VP16 mediated by lentiviral vectors.The JNK pathway as a therapeutic target for diabetes.High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cellsNew sources of pancreatic beta-cells.Chitosan-assisted differentiation of porcine adipose tissue-derived stem cells into glucose-responsive insulin-secreting clusters.Stem cells in the treatment of diabetes.The potential for stem cell therapy in diabetes.Extracellular matrix stiffness dictates Wnt expression through integrin pathway
P2860
Q26798145-4D609A8F-0AFF-429F-B4C0-F2AB266F6E1FQ26862805-CEBC0D08-6E96-4829-8989-83B7F9D02A97Q26864024-09862E2D-7168-476C-BCFD-4092E8601FC2Q26864580-2D6AA4EF-4D51-40CA-87F8-E2790276F0C0Q26991746-83BD8986-ED64-472E-A970-74E9946D7B85Q27007013-A2EDEFBB-221F-463E-9449-EC3566906EB3Q30478228-2AD5B63C-EE96-48F2-BB05-DFB8AB704A1DQ31081664-5A2CC3FB-F41D-42A8-AEFB-A1E22866EAFDQ33410255-BCF5756A-A303-4698-955C-5A9DAE1E4723Q33614702-EADDF64F-BC5B-4707-95F8-0A687DFFC15FQ33692347-69CBA80A-AC6F-46A5-8A8B-80E68BA149E9Q33747741-46E9256C-747A-449D-9E6A-B9E18BA91175Q33759539-E0051216-11D1-4706-A1E8-3A59CFBA3F17Q33815233-7DE86A1B-A26B-45EA-BB06-9D64082F9215Q33820318-1AC53098-A101-444F-B17A-B40EAB25DEE1Q33827066-4CCF5414-E73D-49A9-B8B9-FB4DC491AE65Q33900615-C1865B27-AE49-4214-AEAD-BC29BA3BC9BEQ33982394-1A676344-F97B-4F17-A13E-E8C70FB7426EQ34037254-912EF216-CEA6-42FB-A8C5-19EC915CE3B5Q34043734-43FA8C2E-D5DD-47F1-A463-76481B12C91DQ34117889-961978BB-6C31-4A5D-BABE-E2B00EC1B687Q34233041-D6DD27AE-2D0B-4229-AA9D-879BED35B001Q34259098-13A3323D-E5EC-4313-A5F6-714526159B24Q35048202-BF61A0A6-FD27-46E2-8F97-D2E0C03D9F8FQ35124214-099D7604-F5E7-4B4F-B297-CCCDC83F31D6Q35209577-C1ECB979-6F11-483A-A08B-70A0479F77B1Q35373250-E659C469-AE5F-4505-8AD7-D51B7CCE2B53Q35585661-F017A346-EB12-44F4-BA1E-54A0CEB7420EQ35612728-37BF387B-632F-4933-A327-2D42E658F321Q35752093-548DE7A7-422B-401D-A7D3-907EA4C9C364Q35989150-323F0039-5C25-45D5-833F-7E716E662EE6Q36108470-645FE6CE-D33C-4BF0-99CB-5A4599E76722Q36158409-3641D2CD-F362-40BE-9585-C4D3E212DF5EQ36158726-49FF2E65-3E4E-4FBE-A1A8-8B17FF6C9DD6Q36173431-C63AE139-DB7B-4227-B51E-089C98DEC5E7Q36186494-539E01F7-F529-4939-8B22-E014A05652ACQ36295339-4E42E762-E0A4-4D05-911D-BCA8A16E3D98Q36309570-59F63101-8D71-433A-B7B8-37EA1531ECE4Q36426351-C742F8DC-DD4F-4708-A05F-DD0CEB6D2307Q36555496-8C7AE365-CB77-4D86-B9E0-E5871900AEB0
P2860
In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
In vivo and in vitro character ...... ained from murine bone marrow.
@ast
In vivo and in vitro character ...... ained from murine bone marrow.
@en
type
label
In vivo and in vitro character ...... ained from murine bone marrow.
@ast
In vivo and in vitro character ...... ained from murine bone marrow.
@en
prefLabel
In vivo and in vitro character ...... ained from murine bone marrow.
@ast
In vivo and in vitro character ...... ained from murine bone marrow.
@en
P2093
P2860
P1433
P1476
In vivo and in vitro character ...... ained from murine bone marrow.
@en
P2093
Brant R Burkhardt
Chang-Qi Xia
Dong-Qi Tang
Li-Jun Yang
Li-Zhen Cao
Mark A Atkinson
Sally A Litherland
P2860
P304
P356
10.2337/DIABETES.53.7.1721
P407
P577
2004-07-01T00:00:00Z